154 related articles for article (PubMed ID: 25232966)
21. Design and synthesis of 4-arylpiperidinyl amide and N-arylpiperdin-3-yl-cyclopropane carboxamide derivatives as novel melatonin receptor ligands.
Li G; Zhou H; Jiang Y; Keim H; Topiol SW; Poda SB; Ren Y; Chandrasena G; Doller D
Bioorg Med Chem Lett; 2011 Feb; 21(4):1236-42. PubMed ID: 21237644
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and pharmacological evaluation of new series of naphthalenic analogues as melatoninergic (MT1/MT2) and serotoninergic 5-HT2C dual ligands (I).
Ettaoussi M; Sabaouni A; Rami M; Boutin JA; Delagrange P; Renard P; Spedding M; Caignard DH; Berthelot P; Yous S
Eur J Med Chem; 2012 Mar; 49():310-23. PubMed ID: 22301214
[TBL] [Abstract][Full Text] [Related]
23. Design and synthesis of 3-phenyltetrahydronaphthalenic derivatives as new selective MT2 melatoninergic ligands. Part II.
Durieux S; Chanu A; Bochu C; Audinot V; Coumailleau S; Boutin JA; Delagrange P; Caignard DH; Bennejean C; Renard P; Lesieur D; Berthelot P; Yous S
Bioorg Med Chem; 2009 Apr; 17(8):2963-74. PubMed ID: 19329323
[TBL] [Abstract][Full Text] [Related]
24. Towards the development of mixed MT(1)-agonist/MT(2)-antagonist melatonin receptor ligands.
Spadoni G; Bedini A; Guidi T; Tarzia G; Lucini V; Pannacci M; Fraschini F
ChemMedChem; 2006 Oct; 1(10):1099-105. PubMed ID: 16955531
[TBL] [Abstract][Full Text] [Related]
25. Homology modeling of MT1 and MT2 receptors.
Farce A; Chugunov AO; Logé C; Sabaouni A; Yous S; Dilly S; Renault N; Vergoten G; Efremov RG; Lesieur D; Chavatte P
Eur J Med Chem; 2008 Sep; 43(9):1926-44. PubMed ID: 18255198
[TBL] [Abstract][Full Text] [Related]
26. Highly Potent and Selective MT2 Melatonin Receptor Full Agonists from Conformational Analysis of 1-Benzyl-2-acylaminomethyl-tetrahydroquinolines.
Spadoni G; Bedini A; Lucarini S; Mari M; Caignard DH; Boutin JA; Delagrange P; Lucini V; Scaglione F; Lodola A; Zanardi F; Pala D; Mor M; Rivara S
J Med Chem; 2015 Sep; 58(18):7512-25. PubMed ID: 26334942
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and pharmacological evaluation of dual ligands for melatonin (MT1/MT2) and serotonin 5-HT2C receptor subtypes (II).
Ettaoussi M; Pérès B; Errazani A; Boutin JA; Caignard DH; Delagrange P; Melnyk P; Berthelot P; Yous S
Eur J Med Chem; 2015 Jan; 90():822-33. PubMed ID: 25528336
[TBL] [Abstract][Full Text] [Related]
28. (R)-2-(4-Phenylbutyl)dihydrobenzofuran derivatives as melatoninergic agents.
Sun LQ; Takaki K; Chen J; Bertenshaw S; Iben L; Mahle CD; Ryan E; Wu D; Gao Q; Xu C
Bioorg Med Chem Lett; 2005 Mar; 15(5):1345-9. PubMed ID: 15713384
[TBL] [Abstract][Full Text] [Related]
29. Novel conformationally constrained analogues of agomelatine as new melatoninergic ligands.
Rami M; Landagaray E; Ettaoussi M; Boukhalfa K; Caignard DH; Delagrange P; Berthelot P; Yous S
Molecules; 2012 Dec; 18(1):154-66. PubMed ID: 23262445
[TBL] [Abstract][Full Text] [Related]
30. 2-Arylmelatonin analogues: Probing the 2-phenyl binding pocket of melatonin MT
Mari M; Elisi GM; Bedini A; Lucarini S; Retini M; Lucini V; Scaglione F; Vincenzi F; Varani K; Castelli R; Mor M; Rivara S; Spadoni G
Eur J Med Chem; 2022 Dec; 243():114762. PubMed ID: 36150258
[TBL] [Abstract][Full Text] [Related]
31. Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist.
Kato K; Hirai K; Nishiyama K; Uchikawa O; Fukatsu K; Ohkawa S; Kawamata Y; Hinuma S; Miyamoto M
Neuropharmacology; 2005 Feb; 48(2):301-10. PubMed ID: 15695169
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the Mel1c melatoninergic receptor in platypus (Ornithorhynchus anatinus).
Gautier C; Guenin SP; Riest-Fery I; Perry TJ; Legros C; Nosjean O; Simonneaux V; Grützner F; Boutin JA
PLoS One; 2018; 13(3):e0191904. PubMed ID: 29529033
[TBL] [Abstract][Full Text] [Related]
33. O-linked melatonin dimers as bivalent ligands targeting dimeric melatonin receptors.
Karamitri A; Sadek MS; Journé AS; Gbahou F; Gerbier R; Osman MB; Habib SAM; Jockers R; Zlotos DP
Bioorg Chem; 2019 Apr; 85():349-356. PubMed ID: 30658234
[TBL] [Abstract][Full Text] [Related]
34. Heterocyclic aminopyrrolidine derivatives as melatoninergic agents.
Sun LQ; Chen J; Mattson RJ; Epperson JR; Deskus JA; Li WS; Takaki K; Hodges DB; Iben L; Mahle CD; Ortiz A; Molstad D; Ryan E; Yeleswaram K; Xu C; Luo G
Bioorg Med Chem Lett; 2003 Dec; 13(24):4381-4. PubMed ID: 14643330
[TBL] [Abstract][Full Text] [Related]
35. N-Acetyl-5-arylalkoxytryptamine analogs: probing the melatonin receptors for MT(1) -selectivity.
Markl C; Clafshenkel WP; Attia MI; Sethi S; Witt-Enderby PA; Zlotos DP
Arch Pharm (Weinheim); 2011 Oct; 344(10):666-74. PubMed ID: 21887801
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of 5-substituted-2,3-dihydro-1,4-benzoxathiins: biological evaluation as melatonin receptors ligands.
Charton I; Suzenet F; Boutin JA; Audinot V; Delagrange P; Bennejean C; Renard P; Guillaumet G
J Enzyme Inhib Med Chem; 2003 Apr; 18(2):187-93. PubMed ID: 12943203
[TBL] [Abstract][Full Text] [Related]
37. New selective ligands of human cloned melatonin MT1 and MT2 receptors.
Audinot V; Mailliet F; Lahaye-Brasseur C; Bonnaud A; Le Gall A; Amossé C; Dromaint S; Rodriguez M; Nagel N; Galizzi JP; Malpaux B; Guillaumet G; Lesieur D; Lefoulon F; Renard P; Delagrange P; Boutin JA
Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):553-61. PubMed ID: 12764576
[TBL] [Abstract][Full Text] [Related]
38. Molecular pharmacology of the mouse melatonin receptors MT₁ and MT₂.
Devavry S; Legros C; Brasseur C; Cohen W; Guenin SP; Delagrange P; Malpaux B; Ouvry C; Cogé F; Nosjean O; Boutin JA
Eur J Pharmacol; 2012 Feb; 677(1-3):15-21. PubMed ID: 22202844
[TBL] [Abstract][Full Text] [Related]
39. High-throughput screening assay for new ligands at human melatonin receptors.
Yan JH; Su HR; Boutin JA; Renard MP; Wang MW
Acta Pharmacol Sin; 2008 Dec; 29(12):1515-21. PubMed ID: 19026172
[TBL] [Abstract][Full Text] [Related]
40. Preparation of 4-azaindole and 7-azaindole dimers with a bisalkoxyalkyl spacer in order to preferentially target melatonin MT1 receptors over melatonin MT2 receptors.
Larraya C; Guillard J; Renard P; Audinot V; Boutin JA; Delagrange P; Bennejean C; Viaud-Massuard MC
Eur J Med Chem; 2004 Jun; 39(6):515-26. PubMed ID: 15183910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
